Nadia Dallera

1.2k total citations
16 papers, 370 citations indexed

About

Nadia Dallera is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Nadia Dallera has authored 16 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Nadia Dallera's work include Renal Diseases and Glomerulopathies (6 papers), Aortic Thrombus and Embolism (4 papers) and Aortic aneurysm repair treatments (4 papers). Nadia Dallera is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Aortic Thrombus and Embolism (4 papers) and Aortic aneurysm repair treatments (4 papers). Nadia Dallera collaborates with scholars based in Italy, Canada and Switzerland. Nadia Dallera's co-authors include Francesco Scolari, Pietro Ravani, Gian Marco Ghiggeri, Mirco Belingheri, Rossella Rossi, Andrea Pasini, Felice Sica, Alberto Edefonti, Elisa Benetti and Luciana Ghio and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Nadia Dallera

15 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Dallera Italy 7 315 135 113 76 59 16 370
Durga Kanigicherla United Kingdom 9 371 1.2× 162 1.2× 191 1.7× 30 0.4× 71 1.2× 27 407
Shane A. Bobart United States 9 236 0.7× 79 0.6× 118 1.0× 37 0.5× 69 1.2× 28 296
Patrizia Melis Italy 4 379 1.2× 143 1.1× 94 0.8× 30 0.4× 49 0.8× 6 414
Christian D’Altri Italy 6 298 0.9× 67 0.5× 40 0.4× 28 0.4× 65 1.1× 7 340
Marine Andreani France 7 220 0.7× 112 0.8× 107 0.9× 38 0.5× 20 0.3× 11 291
Masami Fujisaki Japan 7 180 0.6× 70 0.5× 33 0.3× 37 0.5× 65 1.1× 8 291
Giuseppe D'Amico Italy 6 231 0.7× 36 0.3× 103 0.9× 31 0.4× 53 0.9× 10 313
Yaling Zhai China 9 290 0.9× 58 0.4× 49 0.4× 33 0.4× 45 0.8× 22 386
A. Séchet France 8 175 0.6× 40 0.3× 33 0.3× 52 0.7× 136 2.3× 13 296
F Buzelin France 9 187 0.6× 59 0.4× 100 0.9× 31 0.4× 76 1.3× 32 342

Countries citing papers authored by Nadia Dallera

Since Specialization
Citations

This map shows the geographic impact of Nadia Dallera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Dallera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Dallera more than expected).

Fields of papers citing papers by Nadia Dallera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Dallera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Dallera. The network helps show where Nadia Dallera may publish in the future.

Co-authorship network of co-authors of Nadia Dallera

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Dallera. A scholar is included among the top collaborators of Nadia Dallera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Dallera. Nadia Dallera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Scolari, Francesco, Elisa Delbarba, Domenico Santoro, et al.. (2021). Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial. Journal of the American Society of Nephrology. 32(4). 972–982. 131 indexed citations
2.
Scolari, Francesco, Nadia Dallera, Loreto Gesualdo, et al.. (2019). Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial. BMJ Open. 9(12). e029232–e029232. 14 indexed citations
3.
Esposito, Ciro, Vincenzo La Milia, Roberta Cerutti, et al.. (2018). [Practical approach to patient therapy affected by Autosomal Dominant Autosomic Polycystic Kidney Disease].. PubMed. 35(4).
4.
Scolari, Francesco, et al.. (2017). [ADPKD: predictors of Renal Disease progression].. PubMed. 33(5). 1 indexed citations
5.
Izzi, Claudia, Nadia Dallera, Cinzia Mazza, et al.. (2017). [Genetics and genetic counseling].. PubMed. 33(2). 1 indexed citations
6.
Delbarba, Elisa, et al.. (2016). [Hyperuricemia and Gout].. PubMed. 33(S68). 4 indexed citations
7.
Izzi, Claudia, et al.. (2016). Congenital Anomalies of the Kidney and the Urinary Tract (CAKUT). 28(2). 79–82. 1 indexed citations
8.
Gregorini, Gina, Claudia Izzi, Pietro Ravani, et al.. (2015). Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. Kidney International. 87(6). 1223–1229. 30 indexed citations
9.
Delbarba, Elisa, Bruno U. Pedroni, Nadia Dallera, Claudia Izzi, & Francesco Scolari. (2015). [Genetics of mesangial IgA nephropathy].. PubMed. 32 Suppl 64. 2 indexed citations
10.
Izzi, Claudia, Nadia Dallera, Chiara Manenti, et al.. (2014). The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia. Kidney International. 86(4). 863–864. 2 indexed citations
11.
Ravani, Pietro, Alberto Magnasco, Alberto Edefonti, et al.. (2011). Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome. Clinical Journal of the American Society of Nephrology. 6(6). 1308–1315. 154 indexed citations
12.
Passerini, Patrizia, Francesco Scolari, Giovanni M. Frascà, et al.. (2009). [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].. PubMed. 26(5). 563–76. 3 indexed citations
13.
Ravani, Pietro, Rossella Gaggi, Cristiana Rollino, et al.. (2009). Lack of Association between Dialysis Modality and Outcomes in Atheroembolic Renal Disease. Clinical Journal of the American Society of Nephrology. 5(3). 454–459. 6 indexed citations
14.
Mazzola, Giuseppe, Claudio Venturelli, Francesca Valerio, et al.. (2009). [Atheroembolic renal disease].. PubMed. 26(2). 181–90. 6 indexed citations
15.
Dallera, Nadia, et al.. (2006). Cholesterol crystal embolism (atheroembolism). Heart International. 2(3-4). 155–155. 13 indexed citations
16.
Dallera, Nadia, et al.. (2006). Cholesterol Crystal Embolism (Atheroembolism). Heart International. 2(3-4). 966141576–966141576. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Durga Kanigicherla Breakdown of academic impact, for papers by Shane A. Bobart Breakdown of academic impact, for papers by Patrizia Melis Breakdown of academic impact, for papers by Christian D’Altri Breakdown of academic impact, for papers by Marine Andreani Breakdown of academic impact, for papers by Masami Fujisaki Breakdown of academic impact, for papers by Giuseppe D'Amico Breakdown of academic impact, for papers by Yaling Zhai Breakdown of academic impact, for papers by A. Séchet Breakdown of academic impact, for papers by F Buzelin
Rankless by CCL
2026